RNA Clinical Trials Solutions

1. The Future Of Reimbursement For Cell & Gene Therapies 7/27/2022

   Our team excels at understanding the ever-changing and complex healthcare market and helping clients solve issues. Learn about the payer challenges, potential reimbursements, and the competition to consider.  

2. Early Phase Trials In Australia 9/6/2024

   Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.

3. Real World Data 6/27/2023

   Accelerate patient recruitment and drug development with real world data (RWD).

4. Site Management Organization 11/7/2023

   Discover the power of clinical excellence with Acrostar's SMO Division, a dedicated entity operating as part of Novotech.

5. Novotech Laboratory Services 11/7/2023

   Our bioanalytical services assist our customers in every stage of their molecule development.

6. Clinical Operations And Project Management For Every Phase 12/21/2022

   Get streamlined and integrated clinical trial services delivered by a dedicated team of professionals with deep industry and therapeutic area expertise across all phases of clinical development. 

7. Oncology CRO Services 6/27/2023

   Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes, and relatively high costs.

8. Orphan And Rare Disease CRO Services 11/7/2023

   Rare Disease clinical studies demand a specialized full-service CRO with expertise in enrollment, site selection, and global regulatory knowledge, including access to patient registries for accelerated recruitment.

9. New Next-Generation GMP Facility 5/16/2023

   A new state-of-the-art GMP facility has been created to accelerate the development of CRISPR-based cell and gene therapies, overcoming challenges such as procuring reliable GMP-grade sgRNA persist.

10. Comprehensive Data And Analytics For Cell, Gene, And RNA-Based Therapies 10/19/2022

    Stay on top of changes in the ever-evolving world of cell and gene therapies and more. Our in-house subject matter experts comb through the data weekly to ensure we provide you with the most current and comprehensive information important to this market.